Absorption Study of Genistein Using Solid Lipid Microparticles and Nanoparticles: Control of Oral Bioavailability by Particle Sizes |
Kim, Jeong Tae
(College of Pharmacy, Graduate School of Pharmaceutical Management, Chung-Ang University)
Barua, Sonia (College of Pharmacy, Graduate School of Pharmaceutical Management, Chung-Ang University) Kim, Hyeongmin (College of Pharmacy, Graduate School of Pharmaceutical Management, Chung-Ang University) Hong, Seong-Chul (College of Pharmacy, Graduate School of Pharmaceutical Management, Chung-Ang University) Yoo, Seung-Yup (College of Pharmacy, Graduate School of Pharmaceutical Management, Chung-Ang University) Jeon, Hyojin (College of Pharmacy, Graduate School of Pharmaceutical Management, Chung-Ang University) Cho, Yeongjin (Department of Pharmaceutical Industry, Graduate School of Pharmaceutical Management, Chung-Ang University) Gil, Sangwon (Department of Pharmaceutical Industry, Graduate School of Pharmaceutical Management, Chung-Ang University) Oh, Kyungsoo (College of Pharmacy, Graduate School of Pharmaceutical Management, Chung-Ang University) Lee, Jaehwi (College of Pharmacy, Graduate School of Pharmaceutical Management, Chung-Ang University) |
1 | Li, Y., Sun, D., Palmisano, M. and Zhou, S. (2016) Slow drug delivery decreased total body clearance and altered bioavailability of immediate-and controlled-release oxycodone formulations. Pharmacol. Res. Perspect. 4, e00210. DOI |
2 | Luo, Y., Chen, D. W., Ren, L. X., Zhao, X. L. and Qin, J. (2006) Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Release 114, 53-59. DOI |
3 | Mathot, F., Van Beijsterveldt, L., Preat, V., Brewster, M. and Arien, A. (2006) Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. J. Control. Release 111, 47-55. DOI |
4 | Mehnert, W. and Mader, K. (2001) Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47, 165-196. DOI |
5 | Muller, R. H., Mader, K. and Gohla, S. (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm. 50, 161-177. DOI |
6 | Muller, R. H., Runge, S., Ravell, V., Mehnert, W., Thunemann, A. F. and Souto, E. B. (2006) Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. Int. J. Pharm. 317, 82-89. DOI |
7 | Munish, A., Meenakshi, B. and Komal, S. (2016) Sodium alginate-arabinoxylan composite microbeads: preparation and characterization. J. Pharm. Investig. 46, 645-653. DOI |
8 | Pankaj, V. D., Ritu, M. G. and Shashikant, N. D. (2016) Formulation and development of solid self micro-emulsifying drug delivery system (S-SMEDDS) containing chlorthalidone for improvement of dissolution. J. Pharm. Investig. 46, 633-644. DOI |
9 | Reithmeier, H., Herrmann, J. and Gopferich, A. (2001) Lipid microparticles as a parenteral controlled release device for peptides. J. Control. Release 73, 339-350. DOI |
10 | Boyd, B. J., Khoo, S. M., Whittaker, D. V., Davey, G. and Porter, C. J. (2007) A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. Int. J. Pharm. 340, 52-60. DOI |
11 | Desai, J. and Thakkar, H. (2016) Effect of particle size on oral bioavailability of darunavir-loaded solid lipid nanoparticles. J. Microencapsul. 33, 669-678. DOI |
12 | Dingler, A. and Gohla, S. (2002) Production of solid lipid nanoparticles (SLN): scaling up feasibilities. J. Microencapsul. 19, 11-16. DOI |
13 | Dixon, R. A. and Ferreira, D. (2002) Genistein. Phytochemistry 60, 205-211. DOI |
14 | Tang, J., Xu, N., Ji, H., Liu, H., Wang, Z. and Wu, L. (2011) Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment. Int. J. Nanomedicine 6, 2429-2435. |
15 | Scalia, S., Young, P. M. and Traini, D. (2015) Solid lipid microparticles as an approach to drug delivery. Expert. Opin. Drug Deliv. 12, 583-599. DOI |
16 | Shelnutt, S. R., Cimino, C. O., Wiggins, P. A., Ronis, M. J. and Badger, T. M. (2002) Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am. J. Clin. Nutr. 76, 588-594. DOI |
17 | Takeuchi, H., Matsui, Y., Yamamoto, H. and Kawashima, Y. (2003) Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J. Control. Release 86, 235-242. DOI |
18 | Tripathi, S., Kushwah, V., Thanki, K. and Jain, S. (2016) Triple antioxidant SNEDDS formulation with enhanced oral bioavailability: Implication of chemoprevention of breast cancer. Nanomedicine 12, 1431-1443. DOI |
19 | Uner, M. and Yener, G. (2007) Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomedicine 2, 289-300. |
20 | Yang, Z., Kulkarni, K., Zhu, W. and Hu, M. (2012) Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME. Anticancer Agents Med. Chem. 12, 1264-1280. DOI |
21 | Lee, S. H., Kim, Y. H., Yu, H. J., Cho, N. S., Kim, T. H., Kim, D. C., Chung, C. B., Hwang, Y. I. and Kim, K. H. (2007) Enhanced bioavailability of soy isoflavones by complexation with beta-cyclodextrin in rats. Biosci. Biotechnol. Biochem. 71, 2927-2933. DOI |
22 | Zhang, Y., Song, T. T., Cunnick, J. E., Murphy, P. A. and Hendrich, S. (1999) Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J. Nutr. 129, 399-405. DOI |
23 | Drover, D. R., Angst, M. S., Valle, M., Ramaswamy, B., Naidu, S., Stanski, D. R. and Verotta, D. (2002) Input characteristics and bioavailability after administration of immediate and a new extendedrelease formulation of hydromorphone in healthy volunteers. Anesthesiology 97, 827-836. DOI |
24 | Emami, J., Mohiti, H., Hamishehkar, H. and Varshosaz, J. (2015) Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design. Res. Pharm. Sci. 10, 17-33. |
25 | Harde, H., Das, M. and Jain, S. (2011) Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert. Opin. Drug Deliv. 8, 1407-1424. DOI |
26 | Horter, D. and Dressman, J. B. (2001) Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 46, 75-87. DOI |
27 | Kumar, D. S. and Pandit, J. K. (1997) Relationship between dissolution rate and bioavailability of sustained-release ibuprofen capsules. Drug Dev. Ind. Pharm. 23, 987-992. DOI |
28 | Kwon, S. H., Kim, S. Y., Ha, K. W., Kang, M. J., Huh, J. S., Im, T. J., Kim, Y. M., Park, Y. M., Kang, K. H., Lee, S., Chang, J. Y., Lee, J. and Choi, Y. W. (2007) Pharmaceutical evaluation of genisteinloaded pluronic micelles for oral delivery. Arch. Pharm. Res. 30, 1138-1143. DOI |
29 | Li, H. L., Zhao, X. B., Ma, Y. K., Zhai, G. X., Li, L. B. and Lou, H. X. (2009) Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release 133, 238-244. DOI |